Advertisement
Concise Publication Free access | 10.1172/JCI106640
1Department of Medicine, Section of Cardiology, University of Illinois Hospital and College of Medicine, Chicago, Illinois 60612
Find articles by Taylor, G. in: JCI | PubMed | Google Scholar
1Department of Medicine, Section of Cardiology, University of Illinois Hospital and College of Medicine, Chicago, Illinois 60612
Find articles by Harris, W. in: JCI | PubMed | Google Scholar
1Department of Medicine, Section of Cardiology, University of Illinois Hospital and College of Medicine, Chicago, Illinois 60612
Find articles by Bogdonoff, M. in: JCI | PubMed | Google Scholar
Published July 1, 1971 - More info
After inhaling fluoroalkane gases, which are used as aerosol propellants, some people have died suddently and unexpectedly. Seeking an explanation, we had 14 monkeys inhale these gases. All developed ventricular premature beats, bigeminy, or tachycardia, which began at an average of 39 (SE ±4.2) sec. Fluoroalkanes were present in blood, but arterial hypoxemia or hypercapnia was absent, and arterial pressure was reduced only slightly. In contrast, without fluoroalkanes, 3 min of asphyxia or anoxia caused arrhythmias in only one monkey whose arterial oxygen tension had fallen to 16 mm Hg. The ventricular arrhythmias caused in well oxygenated monkeys by fluoroalkane gases may either be mediated through beta adrenergic receptors, since propranolol abolished these arrhythmias, or result from a nonadrenergic, direct, toxic effect of these gases on the heart. These results suggest that some deaths after propellant inhalation may be caused by ventricular tachycardia or fibrillation.
Images.